GTT Data Solutions has accepted the resignations of Deepak Shinde and Nitin Patil from its Board of Directors effective June 15, 2026. The resignations were submitted pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Both directors have also stepped down from all committee positions they held on the Board.

Deepak Shinde, who served as a Non-Executive Independent Director, cited a change in his personal interests within an organization forming part of the promoter group as the reason for his departure. In his resignation letter, Shinde stated that continuing on the Board could be perceived to compromise his independence. He confirmed that there are no other material reasons for his resignation beyond those stated.

Nitin Patil, a Non-Executive Non-Independent Director, resigned due to increased professional and personal commitments requiring greater attention and time. He stated that he is unable to devote sufficient time to the affairs of the company. Patil also confirmed that there are no material reasons for his resignation other than those disclosed in his letter.

The Board of Directors placed on record its sincere appreciation for the valuable guidance, support, and contributions made by both directors during their tenure. The company disclosed that neither Shinde nor Patil holds directorships in any other listed entity as of the date of their resignation letters.

The details of the resignations were furnished in Annexure-A to the filing submitted to BSE Limited. The company confirmed that the necessary disclosures would be filed with the stock exchanges and regulatory authorities.

GTT Data Solutions has strengthened its board governance by appointing Dr. Charudatta Palwe as an Additional Independent Director. The appointment, effective June 9, 2026, is for a five-year term concluding on June 8, 2031, and remains subject to approval by the company's shareholders. This strategic move aims to bolster the board with independent oversight as the company continues its operations.

The Board of Directors approved the appointment through a resolution dated June 8, 2026. Dr. Palwe satisfies the criteria for independence prescribed under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that he is not related to any existing director and is not debarred from holding the director position by any order from SEBI or other authorities.

Profile of the New Director

Dr. Charudatta Prabhakar Palwe brings a diverse professional background to the role. A medical doctor and biomedical engineer, he possesses expertise in healthcare administration, business development, and strategic planning. His experience spans operational management, budget control, and organizational leadership, with a focus on technology, marketing, and rural healthcare in India.

The appointment was disclosed to the stock exchanges in compliance with Regulation 30 of the SEBI LODR Regulations. The requisite details, including those required under SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, were submitted as part of the regulatory filing.

Appointment Details